Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;40(3):331-338.
doi: 10.1080/02813432.2022.2139363. Epub 2022 Nov 11.

Preventive effect of methenamine in women with recurrent urinary tract infections - a case-control study

Linda Rui  1 , Morten Lindbaek  1 , Svein Gjelstad  1
Affiliations

Preventive effect of methenamine in women with recurrent urinary tract infections - a case-control study

Linda Rui et al. Scand J Prim Health Care. 2022 Sep.

Abstract

Background: Urinary tract infection (UTI) is the most common bacterial infection in women. In Norwegian general practice, methenamine has been prescribed for many years as long-term prevention and accounted for 20% of the total antibiotic prescribing in 2015, as measured in defined daily dosages (DDDs). The efficacy of methenamine is unknown. If shown to be effective, this drug may become an important preventive against UTI.

Objective: To examine whether methenamine is preventive against recurrent UTI in women.

Design: Data for all antibiotics used for UTIs dispensed from all pharmacies from 2005 to 2015 were collected from the Norwegian prescription database (NorPD).

Subjects: Women aged ≥ 40 years with recurrent UTI, defined as ≥3 courses of UTI antibiotic/year, were included.

Main outcome measures: Patients using methenamine (cases) and those not using methenamine (controls) were compared. The numbers of UTI prescriptions during the 2 years before and after inclusion were analysed. Results: The yearly prevalence for recurrent UTI was 2.4% in women ≥ 40 years. The change in antibiotic use from 2 years before to 2 years after inclusion in the study differed significantly between groups: 44.6 and 34.9% reductions in the number of antibiotic prescriptions for UTI in the methenamine and control groups, respectively. The decrease in UTI antibiotic prescriptions (58.9%) was greater in patients with a higher consumption of antibiotics before starting methenamine.

Conclusions: Methenamine seems to be effective against recurrent UTI over the time span studied. The effect seems to be greater in patients with the highest number of recurrent UTIs. Key pointsMethenamine has been used for many years for prevention of recurrent UTI, but no studies have demonstrated a significant preventive effect of long time use.This study shows that methenamine seems to be effective for prevention in patients having recurrent UTI over 2 years or more.The effect seems to be larger in patients with a high number of UTIs over 2 years.

Keywords: Recurrent infection; antibiotics; methenamine; urinary tract infection; women.

PubMed Disclaimer

Conflict of interest statement

All authors declare to have no conflict of interest.

Figures

Figure 1.
Figure 1.
Flow chart for the inclusion and exclusion of patients, data obtained from NorPD.
Figure 1.
Figure 1.
Flow chart for the inclusion and exclusion of patients, data obtained from NorPD.
Figure 2.
Figure 2.
Prevalence of methenamine use per 1000 women in 2015 in Norway, by age group, data obtained from NorPD [28].
See this image and copyright information in PMC

References

    1. Barclay J, Veeratterapillay R, Harding C.. Non-antibiotic options for recurrent urinary tract infections in women. BMJ. 2017;359:j5193. - PubMed
    1. Davis C, Rantell A.. Lower urinary tract infections in women. Br J Nurs. 2017;26(9):S12–S19. - PubMed
    1. Aydin A, Ahmed K, Zaman I, et al. . Recurrent urinary tract infections in women. Int Urogynecol J. 2015;26(6):795–804. - PubMed
    1. Colgan R, Williams M.. Diagnosis and treatment of acute uncomplicated cystitis. Am Fam Physician. 2011;84(7):771–776. - PubMed
    1. van Buul LW, van der Steen JT, Veenhuizen RB, et al. . Antibiotic use and resistance in long term care facilities. J Am Med Dir Assoc. 2012;13(6):568.e1–13–568.13. - PubMed

MeSH terms

LinkOut - more resources